Sarepta Therapeutics (SRPT) drops after big Wednesday hike

Sarepta Therapeutics Inc SRPT shares fell 5.4% to $24.82 after jumping 60.2% on Wednesday. Bank of America downgraded Sarepta Therapeutics from buy to neutral and raised the price target from $20.00 to $28.00. Share volume was 2.6 million, better than double an all-day average of 1.2 million